Get the Stockscreener App
20.79
3.87%
-0.8564
Procept Biorobotics Corp stock is traded at $20.79, with a volume of 386.42K.
It is down -3.87% in the last 24 hours and up +8.29% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$21.65
Open:
$21.28
24h Volume:
386.42K
Relative Volume:
0.23
Market Cap:
$1.19B
Revenue:
$322.02M
Net Income/Loss:
$-102.47M
P/E Ratio:
-11.37
EPS:
-1.8295
Net Cash Flow:
$-80.57M
1W Performance:
-4.13%
1M Performance:
+8.29%
6M Performance:
-25.99%
1Y Performance:
-49.96%
1-Day Range:
$20.78
$21.63
1-Week Range:
$20.80
$22.93
52-Week Range:
$16.66
$42.43
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
20.78 | 1.24B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
110.05 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.95 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.59 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.51 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.72 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 22, 2026 - The Spec
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026 - GlobeNewswire
The Bull Case For PROCEPT BioRobotics (PRCT) Could Change Following Q2 Losses Amid Strong Revenue Growth - simplywall.st
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - PR Newswire
Johnson & Johnson Invests $8.08 Billion in PROCEPT BioRobotics Corporation $PRCT - marketbeat.com
PROCEPT BioRobotics Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - NewMediaWire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure ... - Caledonian Record
PROCEPT BioRobotics EVP Alaleh Nouri Granted 22,965 RSUs and Stock Options for 31,773 Shares - Kalkine Media
PROCEPT BioRobotics CTO Barry Templin Awarded RSUs and Stock Options in Advance of 2027 Grants - Kalkine Media
PROCEPT BioRobotics (PRCT) awards RSUs and stock options to EVP and CLO - Stock Titan
PROCEPT BioRobotics (PRCT) awards stock options and RSUs to EVP CTO Templin - Stock Titan
PROCEPT BioRobotics (PRCT) awards RSUs and stock options to CFO Kevin Waters - Stock Titan
PROCEPT BioRobotics (PRCT) grants RSUs and options to Chief Strategy & Marketing Officer - Stock Titan
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock DeclineInvestors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - The Globe and Mail
PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 Lead Plaintiff Deadline in Class Action LawsuitHagens Berman - PR Newswire
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Kaplan Fox Urges Investors of PROCEPT BioRobotics Corporation (NA - The National Law Review
PRCT Shareholder Alert: September 22, 2026 Lead Plaintiff - GlobeNewswire
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law - The Malone Telegram
Kaplan Fox Notifies PROCEPT BioRobotics Corporation (NASDAQ: PRCT - The National Law Review
PRCT SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire
Why PROCEPT BioRobotics (PRCT) Could Be 10% Undervalued On Reaffirmed Guidance - Sahm
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 22, 2026 Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) - barchart.com
PROCEPT BioRobotics Corporation Notice of September 22, 2026 Application Deadline for Class Action LawsuitContact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline - TMX Newsfile
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 6.6%Here's What Happened - marketbeat.com
SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026PRCT - PR Newswire
Kaplan Fox Continues to Alert Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Class Action Deadline on September 22, 2026 - theglobeandmail.com
DEADLINE ALERT for WIX, PRCT, and PNR: The Law Offices of - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming DeadlinesPRCT - PR Newswire
67,700 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by Quantinno Capital Management LP - marketbeat.com
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ... - pmg-ky3.com
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026 - The Globe and Mail
PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT BioRobotics Corporation Investors ... - Caledonian Record
PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT - GlobeNewswire
PROCEPT BioRobotics Corp (PRCT) Shares Fall 7.2% -- What GF Scor - GuruFocus
PRCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP - PR Newswire
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.8%What's Next? - marketbeat.com
Kaplan Fox Alerts Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) with Significant Losses to a Securities Class Action Deadline on September 22, 2026 - The Globe and Mail
PRCT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in PROCEPT BIOROBOTICS CORPORATION Securities LawsuitContact Levi & Korsinsky - AOL.com
PROCEPT BIOROBOTICS CORPORATION INVESTORS WITH LOSSES HAVE - GlobeNewswire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory ... - Enidnews.com
PRCT Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - marketscreener.com
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Deadline on September 22, 2026 - Barchart.com
PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Procept Biorobotics Corp Stock (PRCT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nouri Alaleh | EVP, CLO, CORP. SEC. |
Jun 08 '26 |
Sale |
28.48 |
285 |
8,117 |
105,069 |
| Waters Kevin | EVP, CFO |
Jun 08 '26 |
Sale |
28.48 |
357 |
10,167 |
151,201 |
| Templin Barry L | EVP, Chief Technology Officer |
Jun 08 '26 |
Sale |
28.48 |
358 |
10,195 |
68,953 |
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):